CHALLENGES IN THE DEVELOPMENT OF VACCINE VIRUS STRAINS FOR LIVE ATTENUATED INFLUENZA VACCINE BASED ON POTENTIALLY PANDEMIC INFLUENZA VIRUSES
- Authors: BAZHENOVA E.A1, LARIONOVA N.V1, FEDOROVA E.A1, DUBROVINA I.A1, KISELEVA I.V1, RUDENKO L.G1
-
Affiliations:
- Research Institute of Experimental Medicine, North-Western Branch, Russian Academy of Medical Sciences
- Issue: No 6 (2012)
- Pages: 16-20
- Section: Articles
- URL: https://journals.eco-vector.com/2226-6976/article/view/276261
- ID: 276261
Cite item
Abstract
Full Text
About the authors
E. A BAZHENOVA
Research Institute of Experimental Medicine, North-Western Branch, Russian Academy of Medical Sciences
Email: sonya.01.08@mail.ru
Saint Petersburg
N. V LARIONOVA
Research Institute of Experimental Medicine, North-Western Branch, Russian Academy of Medical Sciences
Email: nvlarionova@mail.ru
Saint Petersburg
E. A FEDOROVA
Research Institute of Experimental Medicine, North-Western Branch, Russian Academy of Medical Sciences
Email: dosobaki@gmail.com
Saint Petersburg
I. A DUBROVINA
Research Institute of Experimental Medicine, North-Western Branch, Russian Academy of Medical Sciences
Email: ropsha.home@rambler.ru
Saint Petersburg
I. V KISELEVA
Research Institute of Experimental Medicine, North-Western Branch, Russian Academy of Medical Sciences
Email: irina.v.kiseleva@mail.ru
Saint Petersburg
L. G RUDENKO
Research Institute of Experimental Medicine, North-Western Branch, Russian Academy of Medical Sciences
Email: vaccine@mail.ru
Saint Petersburg
References
- WHO. Initiative for Vaccine Research (IVR). Options for Live Attenuated Influenza Vaccines (LAIV) In the Control of Epidemic and Pandemic Influenza 12—13 June 2007. http://www.who.int/vaccine_research/diseases/influenza/ meeting_120707/en/index.html.
- WHO. Global action plan to increase vaccine supply for influenza vaccines. 2006, Geneva, Belgium. http:// whqlibdoc.who.int/hq/2006/WH0_IVB_06.13_eng. pdf.
- Александрова Г.И. Применение метода генетической рекомбинации для получения вакцинных штаммов вируса гриппа. Вопр. вирусол. 1977; 4: 387—395.
- Wareing M. D., Watson J.M., Brooks M. J., Tannock G. A. Immunogenic and isotype—specific responses to Russian and US cold—adapted influenza a vaccine donor strains A/Leningrad/134/17/57, A/Leningrad/134/47/57, and A/ Ann Arbor/6/60 (H2N2) in mice. J. Med. Virol. 2001; 65: 171—177.
- Klimov A.I., Cox N.J. PCR restriction analysis of genome composition and stability of cold—adapted reassortant live influenza vaccines. J. Virol. Methods 1995; 52: 41—49.
- Об утверждении правил лабораторной практики: приказ Минздравсоцразвития России № 708н от 23.08.2010. http://www.rg.ru/2010/10/22/laboratornaya— praktika—dok.html
- Методы определения показателей качества иммунобиологических препаратов для профилактики и диагностики гриппа: Метод. указания МУ №3.3.2.175803 от 28.09.2003.
- WHO. Statement by WHO Director—General, Dr Margaret Chan 11 June 2009. World now at the start of 2009 influenza pandemic. http://www.who.int/mediacentre/news/ statements/2009/h1n1_pandemic_phase6_20090611/en/ index.html
- WHO. Global alert and response (GAR). Confirmed Human Cases of Avian Influenza A (H5N1). http://www.who.int/ csr/disease/avian_influenza/country/en/
- Zitzow L.A., Rowe T., Morken T. et al. Pathogenesis of avian influenza A (H5N1) viruses in ferrets. J. Virol. 2002; 76(9): 4420—4429.
- Subbarao K., Chen H., Swayne D. et al. Evaluation of genetically modified reassortant H5N1 influenza virus vaccine candidate generated by plasmid—based reverse genetics. Virology 2003; 305: 192—200.
- Rudenko L., Desheva J., Korovkin S. et al. Safety and immunogenicity of live attenuated influenza reassortant H5 vaccine (phase I—II clinical trials). IRV 2008; 2: 203—209.
- «Ультрагривак» — моновакцина типа A(H5N2), для профилактики птичьего гриппа. Регистрационное свидетельство ЛСР—002340/09 от 25.03.2009.) http://grls. rosminzdrav.ru/Grls_View.aspx?idReg=7154&t=eb726df2— f7aa—41ce—b060—4f9340fe025a